These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19795406)

  • 1. Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde.
    Belogurov A; Kozyr A; Ponomarenko N; Gabibov A
    Bioessays; 2009 Nov; 31(11):1161-71. PubMed ID: 19795406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creation of a ribonuclease abzyme through site-directed mutagenesis.
    Fletcher MC; Kuderova A; Cygler M; Lee JS
    Nat Biotechnol; 1998 Nov; 16(11):1065-7. PubMed ID: 9831037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G.
    Wootla B; Dasgupta S; Mallet V; Kazatchkine MD; Nagaraja V; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):229-34. PubMed ID: 16651863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic autoantibodies in clinical autoimmunity and modern medicine.
    Gabibov AG; Ponomarenko NA; Tretyak EB; Paltsev MA; Suchkov SV
    Autoimmun Rev; 2006 May; 5(5):324-30. PubMed ID: 16782557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated catalysis: induction and therapeutic relevance.
    Mahendra A; Sharma M; Rao DN; Peyron I; Planchais C; Dimitrov JD; Kaveri SV; Lacroix-Desmazes S
    Autoimmun Rev; 2013 Apr; 12(6):648-52. PubMed ID: 23207286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic antibodies (abzymes) induced by stable transition-state analogs.
    Nevinsky GA; Semenov DV; Buneva VN
    Biochemistry (Mosc); 2000 Nov; 65(11):1233-44. PubMed ID: 11112839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and characterization of lipase abzyme from phage displayed antibody libraries.
    Leong MK; Chen C; Shar KC; Shiuan D
    Biochem Biophys Res Commun; 2007 Sep; 361(3):567-73. PubMed ID: 17673171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic antibodies and their applications.
    Hanson CV; Nishiyama Y; Paul S
    Curr Opin Biotechnol; 2005 Dec; 16(6):631-6. PubMed ID: 16243512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural catalytic antibodies (abzymes) in normalcy and pathology.
    Nevinsky GA; Kanyshkova TG; Buneva VN
    Biochemistry (Mosc); 2000 Nov; 65(11):1245-55. PubMed ID: 11112840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
    Shoenfeld Y; Aron-Maor A
    J Autoimmun; 2000 Feb; 14(1):1-10. PubMed ID: 10648110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA.
    Baranovskii AG; Kanyshkova TG; Mogelnitskii AS; Naumov VA; Buneva VN; Gusev EI; Boiko AN; Zargarova TA; Favorova OO; Nevinsky GA
    Biochemistry (Mosc); 1998 Nov; 63(11):1239-48. PubMed ID: 9864461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Achievements and prospects of clinical abzymology].
    Suchkov SV; Alekberova ZS; Paleev FN; Naumova TE; Misikov VK; Kriazheva ES; Ponomarenko NA; Gabivov AG
    Vestn Ross Akad Med Nauk; 2005; (9):38-43. PubMed ID: 16250330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Introduction to medical abzymology: the present and the prospect].
    Suchkov SV; Gabibov AG
    Vestn Ross Akad Med Nauk; 2005; (10):44-53. PubMed ID: 16320706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN; Mal'tsev KA; Vvedenskaia OIu; Ponomarenko NA; Isaeva MA; Kimova MV; Tret'iak EB; Shogenov ZS; Alekberova ZS; Gabibov AG; Suchkov SV
    Ter Arkh; 2006; 78(6):59-66. PubMed ID: 16881365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human milk antibodies with polysaccharide kinase activity.
    Karataeva NA; Gorbunov D; Prokudin IV; Buneva VN; Kulminskaya AA; Neustroev KN; Nevinsky GA
    Immunol Lett; 2006 Feb; 103(1):58-67. PubMed ID: 16313972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery.
    Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B
    Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.